
    
      Primary objective :

      The primary objective is to determine for each of the 3 molecular subtypes of glioblastoma
      the predictive performance on 1-year overall survival of in situ immune parameters

      Secondary objectives :

      To identify the best combination of in vivo immune parameters that is predictive of 1-year
      overall survival To determine the impact of immune parameters on overall survival
    
  